Drug profile · INN
regdanvimab
REGKIRONA
regdanvimab (REGKIRONA) is a spike glycoprotein inhibitor.
EMA: withdrawn Antiinfectives for systemic use (J06) J06BD06
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — regdanvimab
- Class
- Antiinfectives for systemic use (J06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
regdanvimab (REGKIRONA) is a spike glycoprotein inhibitor.
Key facts
INN regdanvimab
Brand REGKIRONA
Mechanism Spike glycoprotein inhibitor
Target Spike glycoprotein
Therapeutic class Antiinfectives for systemic use (J06)
ATC code J06BD06
Mechanism of action
Spike glycoprotein inhibitor
Primary target: Spike glycoprotein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is regdanvimab?
regdanvimab (REGKIRONA) is a spike glycoprotein inhibitor.
What is the brand name for regdanvimab?
REGKIRONA is a marketed brand name for regdanvimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.